These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28277824)

  • 1. Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa.
    Dar MJ; Ali H; Khan A; Khan GM
    J Drug Target; 2017 Aug; 25(7):582-596. PubMed ID: 28277824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease.
    Zhang S; Ermann J; Succi MD; Zhou A; Hamilton MJ; Cao B; Korzenik JR; Glickman JN; Vemula PK; Glimcher LH; Traverso G; Langer R; Karp JM
    Sci Transl Med; 2015 Aug; 7(300):300ra128. PubMed ID: 26268315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles for the regulation of intestinal inflammation: opportunities and challenges.
    Nunes R; Neves JD; Sarmento B
    Nanomedicine (Lond); 2019 Oct; 14(19):2631-2644. PubMed ID: 31612773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
    Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
    Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives.
    Kotla NG; Rana S; Sivaraman G; Sunnapu O; Vemula PK; Pandit A; Rochev Y
    Adv Drug Deliv Rev; 2019 Jun; 146():248-266. PubMed ID: 29966684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current pharmaceutical strategies for efficient site specific delivery in inflamed distal intestinal mucosa.
    Sharma S; Sinha VR
    J Control Release; 2018 Feb; 272():97-106. PubMed ID: 29317245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan: a potential polymer for colon-specific drug delivery system.
    Gulbake A; Jain SK
    Expert Opin Drug Deliv; 2012 Jun; 9(6):713-29. PubMed ID: 22530707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
    Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparticulate formulation approach to colon specific drug delivery: current perspectives.
    Asghar LF; Chandran S
    J Pharm Pharm Sci; 2006; 9(3):327-38. PubMed ID: 17207416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
    Ali H; Weigmann B; Collnot EM; Khan SA; Windbergs M; Lehr CM
    Pharm Res; 2016 May; 33(5):1085-92. PubMed ID: 26718953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of the hydroxylase inhibitor DMOG provides enhanced efficacy with reduced systemic exposure in a murine model of colitis.
    Tambuwala MM; Manresa MC; Cummins EP; Aversa V; Coulter IS; Taylor CT
    J Control Release; 2015 Nov; 217():221-7. PubMed ID: 26385165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azo chemistry and its potential for colonic delivery.
    Jain A; Gupta Y; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2006; 23(5):349-400. PubMed ID: 17425512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric Systems for Colon-specific Mesalazine Delivery in the Intestinal Bowel Diseases Management.
    Junior AGT; de Araújo JTC; Duarte JL; Silvestre ALP; Di Filippo LD; Chorilli M
    Curr Med Chem; 2023; 30(12):1351-1367. PubMed ID: 35796458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine.
    Li W; Li Y; Liu Z; Kerdsakundee N; Zhang M; Zhang F; Liu X; Bauleth-Ramos T; Lian W; Mäkilä E; Kemell M; Ding Y; Sarmento B; Wiwattanapatapee R; Salonen J; Zhang H; Hirvonen JT; Liu D; Deng X; Santos HA
    Biomaterials; 2018 Dec; 185():322-332. PubMed ID: 30267958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
    Mura C; Nácher A; Merino V; Merino-Sanjuan M; Carda C; Ruiz A; Manconi M; Loy G; Fadda AM; Diez-Sales O
    Int J Pharm; 2011 Sep; 416(1):145-54. PubMed ID: 21723929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-controlled oral delivery systems for colon targeting.
    Gazzaniga A; Maroni A; Sangalli ME; Zema L
    Expert Opin Drug Deliv; 2006 Sep; 3(5):583-97. PubMed ID: 16948555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
    Sawarkar SP; Deshpande SG; Bajaj AN; Nikam VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1445-54. PubMed ID: 26017284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa.
    Collnot EM; Ali H; Lehr CM
    J Control Release; 2012 Jul; 161(2):235-46. PubMed ID: 22306429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.